2.31%C 7.40 5.37%QQQQ 27.81 2.83%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - The executive vice president and chief administrative officer of Valeant Pharmaceuticals International, a specialty pharmaceutical company, bought 2,049 shares of common stock, according to a Securities and Exchange Commission filing Friday.
| VRX | 19.73 |  -0.36 |
In a Form 4 filed with the SEC, Elisa A. Karlson reported she bought the shares for $17.08 apiece.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
Valeant Pharmaceuticals is based in Aliso Viejo, Calif.
U.S. stocks were mixed on Thursday after retailers reported mostly disappointing sales while other big-name companies announced layoffs and Europ...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
The markets have spoken: risk aversion is still the name of the game and that was obvious since the beginning of the week.
Building your business and corporate credit for your small business.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
